Werewolf Therapeutics share price logo

Werewolf Therapeutics

NASDAQ: HOWL

$0.99

-0.03

(-2.89%)

Live

as on

Werewolf Therapeutics Stock Performance

as on November 7, 2026 at 6:50 am IST

  • Day's Low

    Day's High

    $0.98
    $1.03
    downward going graph

    1.06%

    Downside

    3.99%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.27
    $1.27
    downward going graph

    72.74%

    Downside

    28.22%

    Upside

    downward going graph

Werewolf Therapeutics share price movements today

Previous Close
$1.02
Open
$1.00
Volume
468.2K
Market Cap
$52.0M
Day's Low - High
$0.98 - $1.03
52 Week Low - High
$0.27 - $1.27

Werewolf Therapeutics Historical Returns

1 Month Return
+ 17.2 %
3 Month Return
+ 171.14 %
1 Year Return
-10.66 %
3 Year Return
-65.62 %
5 Year Return
-93.23 %

Werewolf Therapeutics Stock Fundamentals & Key Indicators

Check Werewolf Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.0M

EPS (TTM)

-0.7345

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.46

Industry PE ratio

-3.24

PEG Ratio

-0.02

EBITDA

-22.0M

Revenue (TTM)

21.0M

Profit Margin

86.43%

Return On Equity TTM

-166.98%

Werewolf Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Werewolf Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$52.0M-93.23%-1.4686.43%0.00%
Neutral$91.2B9.03%-28.63-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for Werewolf Therapeutics Stock including INR - Dollar returns

The Werewolf Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Werewolf Therapeutics investment value today

Current value as on today

₹85,983

Returns

-₹14,017

(-14.02%)

Returns from Werewolf Therapeutics Stock

-₹18,811 (-18.81%)

Dollar Impact

₹4,795 (+4.79%)

Analyst Recommendation on Werewolf Therapeutics Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Werewolf Therapeutics. Average target price of $7

Werewolf Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Werewolf Therapeutics.

What analysts predicted

85.85%UPSIDE

Target Price

$7

Current Price

$0.9905

Analyzed by

12 Analysts

Target

$7.00

Werewolf Therapeutics target price $7, a slight upside of 85.85% compared to current price of $0.9905. According to 12 analysts rating.

Indian Investors' Interest in Werewolf Therapeutics Stock

Search interest for Werewolf Therapeutics Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Werewolf Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
1
-
-
-
-
-
-
-
21
Gross Profit
0
0
-
-
0
0
-
-
0
18
Operating Income
-17
-18
-17
-20
-17
-17
-15
-9
-8
8
EBITDA
-14
-15
-14
-18
-16
-16
-14
-6
-11
10
Interest Expense
1
1
1
1
1
1
1
1
1
0
Depreciation
0
0
0
0
0
0
0
0
0
2
Income Before Tax
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Net Profit Margin
37.47%
60.28%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
88.32%

Werewolf Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
16
19
1
-
Gross Profit
0
0
-
13
18
0
-1
Operating Income
-9
-22
-50
-56
-40
-73
-60
EBITDA
-9
-14
-49
-52
-32
-64
-53
Interest Expense
0
-
-
-
3
4
5
Depreciation
0
0
0
1
1
1
1
Income Before Tax
-10
-15
-49
-53
-37
-70
-60
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-10
-14
-49
-53
-37
-70
-60
Net Profit Margin
0.00%
0.00%
0.00%
84.70%
91.15%
3.77%
0.00%

Werewolf Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Operating Cash Flow
-15
-14
-12
-14
-18
-15
-15
-11
-10
6
Investing Cash Flow
0
0
0
0
-
-
-
-
-
0
Financing Cash Flow
20
-9
0
2
-
0
3
2
-
-32
Change in Cash
4
-23
-12
-11
-18
-14
-11
-8
-10
-24

Werewolf Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-15
-49
-53
-37
-70
-60
Operating Cash Flow
-9
-18
-42
-40
-32
-56
-60
Investing Cash Flow
0
0
0
-3
0
0
-
Financing Cash Flow
21
93
109
15
58
13
6
Change in Cash
12
74
66
-28
25
-43
-54

Global Institutional Holdings in Werewolf Therapeutics

Check out the Institutions with significant holdings in Werewolf Therapeutics.

Funds
Holdings
MPM BioVentures 2014, L.P.
9.84%
Ansbert Gadicke
9.84%
Peter Kolchinsky
4.91%
VANGUARD INDEX FUNDS
2.51%
Vanguard
2.51%

Insights on Werewolf Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -49.0K → 20.99M (in $), with an average increase of 100.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -13.53M → 3.67M (in $), with an average increase of 468.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, HOWL stock has moved up by 153.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 892.4% return, outperforming this stock by 907.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 235.0% return, outperforming this stock by 301.3%

About Werewolf Therapeutics

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
OrganisationWerewolf Therapeutics
Headquarters200 Talcott Ave, Watertown, MA, 02472, US
IndustryBiotechnology
CEODaniel J. Hicklin

Key Management of Werewolf Therapeutics

Name

Title

Mr. Michael J. Urban

VP of Finance, Corporate Controller & Principal Financial Officer

Mr. Jonathan Owen

Senior VP, General Counsel & Secretary

Dr. Daniel J. Hicklin Ph.D.

Founder, CEO, President & Director

FAQs

What is Werewolf Therapeutics share price today?

Werewolf Therapeutics share price today is $0.99 as on . Werewolf Therapeutics share today touched a day high of $1.03 and a low of $0.98.

What is the 52 week high and 52 week low for Werewolf Therapeutics share?

Werewolf Therapeutics share touched a 52 week high of $1.27 on and a 52 week low of $0.27 on . Werewolf Therapeutics stock price today i.e. is trending at $0.99,which is 22.01% down from its 52 week high and 266.85% up from its 52 week low.

What is Werewolf Therapeutics's market capitalisation today?

Werewolf Therapeutics market capitalisation is $0.00T as on .

How to invest in Werewolf Therapeutics Stock (HOWL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Werewolf Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Werewolf Therapeutics Stock (HOWL) from India?

Indian investors can start investing in Werewolf Therapeutics (HOWL) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Werewolf Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Werewolf Therapeutics share’s latest price of $0.99 as on November 7, 2026 at 1:20 am IST, you will get 10.0959 shares of Werewolf Therapeutics. Learn more about fractional shares .

What are the returns that Werewolf Therapeutics has given to Indian investors in the last 5 years?

Werewolf Therapeutics stock has given -93.23% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?